- Home
- EXK vs ELVN Comparison
EXK vs ELVN Comparison
Compare EXK & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXK
- ELVN
- Stock Information
- Founded
- EXK 1981
- ELVN 2016
- Country
- EXK Canada
- ELVN United States
- Employees
- EXK N/A
- ELVN N/A
- Industry
- EXK Precious Metals
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- EXK Basic Materials
- ELVN Health Care
- Exchange
- EXK Nasdaq
- ELVN Nasdaq
- Market Cap
- EXK 949.5M
- ELVN 927.8M
- IPO Year
- EXK N/A
- ELVN 2020
- Fundamental
- Price
- EXK $4.69
- ELVN $21.30
- Analyst Decision
- EXK Strong Buy
- ELVN Strong Buy
- Analyst Count
- EXK 3
- ELVN 5
- Target Price
- EXK $6.83
- ELVN $39.60
- AVG Volume (30 Days)
- EXK 18.0M
- ELVN 594.3K
- Earning Date
- EXK 07-31-2025
- ELVN 08-12-2025
- Dividend Yield
- EXK N/A
- ELVN N/A
- EPS Growth
- EXK N/A
- ELVN N/A
- EPS
- EXK N/A
- ELVN N/A
- Revenue
- EXK $217,412,000.00
- ELVN N/A
- Revenue This Year
- EXK $99.18
- ELVN N/A
- Revenue Next Year
- EXK $49.21
- ELVN N/A
- P/E Ratio
- EXK N/A
- ELVN N/A
- Revenue Growth
- EXK 1.72
- ELVN N/A
- 52 Week Low
- EXK $2.46
- ELVN $13.30
- 52 Week High
- EXK $5.67
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- EXK 61.77
- ELVN 55.53
- Support Level
- EXK $4.31
- ELVN $18.53
- Resistance Level
- EXK $5.07
- ELVN $24.11
- Average True Range (ATR)
- EXK 0.27
- ELVN 1.96
- MACD
- EXK 0.03
- ELVN 0.15
- Stochastic Oscillator
- EXK 69.57
- ELVN 55.68
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.